Source author record

Mohammad Mansournia

Mohammad Mansournia appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

1works
1topics
2close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2019arXiv

A threshold-free summary index for quantifying the capacity of covariates to yield efficient treatment rules

The focus of this paper is on quantifying the capacity of covariates in devising efficient treatment rules when data from a randomized trial are available. Conventional one-variable-at-a-time subgroup analysis based on statistical hypothesis testing of covariate-by-treatment interaction is ill-suited for this purpose. The application of decision theory results in treatment rules that compare the expected benefit of treatment given the patient's covariates against a treatment threshold. However, determining treatment threshold is often context-specific, and any given threshold might seem arbitrary at the reporting stages of a clinical trial. We propose a threshold-free metric that quantifies the capacity of a set of covariates towards finding individuals who will benefit the most from treatment. The construct of the proposed metric is comparing the expected outcomes with and without knowledge of covariates when one of a two randomly selected patients are to be treated. We show that the resulting index can also be expressed in terms of integrated treatment benefit as a function of covariates over the entire range of treatment thresholds. We also propose a semi-parametric estimation method suitable for out-of-sample validation and adjustment for optimism. We use data from a clinical trial of preventive antibiotic therapy for reducing exacerbation rate in Chronic Obstructive Pulmonary Disease to demonstrate the calculations in a step-by-step fashion. The proposed index has intuitive and theoretically sound interpretation and can be estimated with relative ease for a wide class of regression models. Beyond the conceptual developments presented in this work, various aspects of estimation and inference for such metrics need to be pursued in future research.